Utilisation de l’hydroxychloroquine dans les pathologies obstétricales récurrentes à médiation immune (en dehors du lupus systémique) : fondements et preuves scientifiques
Open Access
- 27 December 2024
- journal article
- abstracts
- Published by Elsevier in La Revue de Médecine Interne
- Vol. 46 (4) , 220-228
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- The 2023 ACR/EULAR Antiphospholipid Syndrome Classification CriteriaArthritis & Rheumatology, 2023
- Recurrent pregnancy loss: fewer chromosomal abnormalities in products of conception? a meta-analysisJournal of Assisted Reproduction and Genetics, 2022
- Birth Outcomes in Women Who Have Taken Hydroxycholoroquine During Pregnancy: A Prospective Cohort StudyArthritis & Rheumatology, 2021
- Association of Higher Hydroxychloroquine Blood Levels With Reduced Thrombosis Risk in Systemic Lupus ErythematosusArthritis & Rheumatology, 2021
- Hydroxychloroquine early in pregnancy and risk of birth defectsAmerican Journal of Obstetrics and Gynecology, 2021
- Antiphospholipid syndrome and other autoimmune diseases associated with chronic intervillositisArchives of Gynecology and Obstetrics, 2014
- Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expressionAmerican Journal of Obstetrics and Gynecology, 2011
- The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosusArthritis & Rheumatism, 2010
- Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2006
- Evidence of transplacental passage of hydroxychloroquine in humansArthritis & Rheumatism, 2002